IL103125A0 - Unsaturated acyclic phosphonate derivatives of purine and pyrimidine and pharmaceutical compositions containing them - Google Patents
Unsaturated acyclic phosphonate derivatives of purine and pyrimidine and pharmaceutical compositions containing themInfo
- Publication number
- IL103125A0 IL103125A0 IL103125A IL10312592A IL103125A0 IL 103125 A0 IL103125 A0 IL 103125A0 IL 103125 A IL103125 A IL 103125A IL 10312592 A IL10312592 A IL 10312592A IL 103125 A0 IL103125 A0 IL 103125A0
- Authority
- IL
- Israel
- Prior art keywords
- purine
- pyrimidine
- pharmaceutical compositions
- compositions containing
- unsaturated acyclic
- Prior art date
Links
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 title 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title 1
- -1 Unsaturated acyclic phosphonate derivatives Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP91402427A EP0531597A1 (de) | 1991-09-12 | 1991-09-12 | Ungesättigte azyklische Phosphonsäure Purinderivats und Pyrimidinderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL103125A0 true IL103125A0 (en) | 1993-02-21 |
Family
ID=8208612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL103125A IL103125A0 (en) | 1991-09-12 | 1992-09-10 | Unsaturated acyclic phosphonate derivatives of purine and pyrimidine and pharmaceutical compositions containing them |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP0531597A1 (de) |
| JP (1) | JPH05247070A (de) |
| KR (1) | KR930006036A (de) |
| AU (1) | AU646758B2 (de) |
| CA (1) | CA2078030A1 (de) |
| FI (1) | FI924077A (de) |
| HU (1) | HUT62009A (de) |
| IL (1) | IL103125A0 (de) |
| NO (1) | NO923539L (de) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5817647A (en) * | 1993-04-01 | 1998-10-06 | Merrell Pharmaceuticals Inc. | Unsaturated acetylene phosphonate derivatives of purines |
| EP0618214A1 (de) * | 1993-04-01 | 1994-10-05 | Merrell Dow Pharmaceuticals Inc. | Ungesättigte Phosphonatderivate Purinen und Pyrimidinen |
| US5656745A (en) * | 1993-09-17 | 1997-08-12 | Gilead Sciences, Inc. | Nucleotide analogs |
| US5798340A (en) | 1993-09-17 | 1998-08-25 | Gilead Sciences, Inc. | Nucleotide analogs |
| EP0719274A1 (de) * | 1993-09-17 | 1996-07-03 | Gilead Sciences, Inc. | Verfahren zur dosierung von therapeutischer verbindungen |
| US5446045A (en) * | 1993-12-20 | 1995-08-29 | Revankar; Ganapathi R. | Antiviral guanine analogs |
| US5994321A (en) * | 1993-12-20 | 1999-11-30 | Aronex Pharmaceuticals, Inc. | Antiviral guanine analogs |
| IL150060A0 (en) * | 1999-12-17 | 2002-12-01 | Ariad Pharma Inc | Novel purines |
| JP2003531111A (ja) | 1999-12-17 | 2003-10-21 | アライアッド・ファーマシューティカルズ・インコーポレーテッド | プロトンポンプインヒビター |
| KR100891366B1 (ko) * | 2001-06-29 | 2009-04-02 | 인스티튜트 오브 오르가닉 케미스트리 앤드 바이오케미스트리, 어케더미 오브 사이언시스 오브 더 체크 리퍼블릭 | 항 바이러스 활성을 갖는 6-'2-(포스포노메톡시)알콕시 피리미딘 유도체 |
| BR0309557A (pt) | 2002-04-26 | 2005-03-01 | Gilead Sciences Inc | Inibidores da transcriptase reversa não nucleosìdeos |
| WO2005002626A2 (en) | 2003-04-25 | 2005-01-13 | Gilead Sciences, Inc. | Therapeutic phosphonate compounds |
| US7432261B2 (en) | 2003-04-25 | 2008-10-07 | Gilead Sciences, Inc. | Anti-inflammatory phosphonate compounds |
| EA014685B1 (ru) | 2003-04-25 | 2010-12-30 | Джилид Сайэнс, Инк. | Фосфонатсодержащие антивирусные соединения (варианты) и фармацевтическая композиция на их основе |
| US7407965B2 (en) | 2003-04-25 | 2008-08-05 | Gilead Sciences, Inc. | Phosphonate analogs for treating metabolic diseases |
| US7452901B2 (en) | 2003-04-25 | 2008-11-18 | Gilead Sciences, Inc. | Anti-cancer phosphonate analogs |
| US7427636B2 (en) | 2003-04-25 | 2008-09-23 | Gilead Sciences, Inc. | Inosine monophosphate dehydrogenase inhibitory phosphonate compounds |
| US7470724B2 (en) | 2003-04-25 | 2008-12-30 | Gilead Sciences, Inc. | Phosphonate compounds having immuno-modulatory activity |
| AU2004233897A1 (en) | 2003-04-25 | 2004-11-11 | Gilead Sciences, Inc. | Kinase inhibitor phosphonate conjugates |
| WO2004096285A2 (en) | 2003-04-25 | 2004-11-11 | Gilead Sciences, Inc. | Anti-infective phosphonate conjugates |
| AU2004260789B2 (en) | 2003-07-30 | 2011-06-30 | Gilead Sciences, Inc. | Nucleobase phosphonate analogs for antiviral treatment |
| US7432273B2 (en) | 2003-10-24 | 2008-10-07 | Gilead Sciences, Inc. | Phosphonate analogs of antimetabolites |
| US7427624B2 (en) | 2003-10-24 | 2008-09-23 | Gilead Sciences, Inc. | Purine nucleoside phosphorylase inhibitory phosphonate compounds |
| EP1678321A1 (de) | 2003-10-24 | 2006-07-12 | Gilead Sciences, Inc. | Verfahren und zusammensetzungen zur identifizierung therapeutischer verbindungen |
| NZ547907A (en) | 2003-12-22 | 2010-07-30 | Gilead Sciences Inc | 4'-Substituted carbovir-and abacavir-derivatives as well as related compounds with HIV and HCV antiviral activity |
| UA88313C2 (ru) | 2004-07-27 | 2009-10-12 | Гилиад Сайенсиз, Инк. | Фосфонатные аналоги соединений ингибиторов вич |
| WO2006137953A1 (en) * | 2005-04-01 | 2006-12-28 | The Regents Of The Univerisity Of California | Phosphono-pent-2-en-1-yl nucleosides and analogs |
| EP1906971A2 (de) * | 2005-07-27 | 2008-04-09 | Gilead Sciences, Inc. | Antivirale verbindungen |
| WO2008100447A2 (en) | 2007-02-09 | 2008-08-21 | Gilead Sciences, Inc. | Nucleoside analogs for antiviral treatment |
| EA018308B1 (ru) | 2008-07-08 | 2013-07-30 | Джилид Сайэнс, Инк. | Соли соединений ингибиторов вич |
| ES2874774T3 (es) | 2011-12-22 | 2021-11-05 | Geron Corp | Análogos de guanina como sustratos de telomerasa y afectores de la longitud de los telómeros |
| PL3661937T3 (pl) | 2017-08-01 | 2021-12-20 | Gilead Sciences, Inc. | Formy krystaliczne ((s)-((((2r,5r)-5-(6-amino-9h-puryn-9-ylo)-4-fluoro-2,5-dihydrofuran-2-ylo)oksy)metylo)(fenoksy)fosforylo)-l-alaninianu etylu (gs-9131) do leczenia zakażeń wirusowych |
| CA3077213A1 (en) | 2017-10-04 | 2019-04-11 | Avidity Biosciences, Inc. | Nucleic acid-polypeptide compositions and uses thereof |
| WO2019136180A2 (en) * | 2018-01-04 | 2019-07-11 | Avidity Biosciences Llc | Heteroduplex nucleic acid molecules and uses thereof |
| EP3784680A1 (de) | 2018-04-23 | 2021-03-03 | Centre national de la recherche scientifique | Neue antivirale acyclonukleosid-analoga |
| CN114375297A (zh) | 2019-06-06 | 2022-04-19 | 艾维迪提生物科学公司 | Una亚酰胺及其用途 |
| CN114375296A (zh) | 2019-06-06 | 2022-04-19 | 艾维迪提生物科学公司 | 核酸多肽组合物及其用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0353955A3 (de) * | 1988-08-02 | 1991-08-14 | Beecham Group Plc | Chemische Verbindungen |
| ATE133678T1 (de) * | 1990-07-04 | 1996-02-15 | Merrell Dow Pharma | 9-purinyl-phosphonsäurederivate |
| WO1992001698A1 (en) * | 1990-07-19 | 1992-02-06 | Beecham Group Plc | Antiviral phosphono-alken derivatives of purines |
-
1991
- 1991-09-12 EP EP91402427A patent/EP0531597A1/de not_active Withdrawn
-
1992
- 1992-09-08 AU AU22197/92A patent/AU646758B2/en not_active Ceased
- 1992-09-09 KR KR1019920016534A patent/KR930006036A/ko not_active Application Discontinuation
- 1992-09-10 IL IL103125A patent/IL103125A0/xx unknown
- 1992-09-11 CA CA002078030A patent/CA2078030A1/en not_active Abandoned
- 1992-09-11 FI FI924077A patent/FI924077A/fi unknown
- 1992-09-11 JP JP4267791A patent/JPH05247070A/ja active Pending
- 1992-09-11 EP EP92402487A patent/EP0532423A1/de not_active Withdrawn
- 1992-09-11 NO NO92923539A patent/NO923539L/no unknown
- 1992-09-11 HU HU9202924A patent/HUT62009A/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2219792A (en) | 1993-03-18 |
| FI924077A (fi) | 1993-03-13 |
| FI924077A0 (fi) | 1992-09-11 |
| EP0531597A1 (de) | 1993-03-17 |
| KR930006036A (ko) | 1993-04-20 |
| HUT62009A (en) | 1993-03-29 |
| NO923539L (no) | 1993-03-15 |
| CA2078030A1 (en) | 1993-03-13 |
| AU646758B2 (en) | 1994-03-03 |
| EP0532423A1 (de) | 1993-03-17 |
| JPH05247070A (ja) | 1993-09-24 |
| NO923539D0 (no) | 1992-09-11 |
| HU9202924D0 (en) | 1992-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL103125A0 (en) | Unsaturated acyclic phosphonate derivatives of purine and pyrimidine and pharmaceutical compositions containing them | |
| NZ245439A (en) | Pyridine and pyrimidine derivatives of indol-3-yl-alkyl piperazines and pharmaceutical compositions thereof | |
| IL88765A0 (en) | Adenosine derivatives and pharmaceutical compositions containing them | |
| NZ236625A (en) | Pyrimidine derivatives and pharmaceutical compositions | |
| HUT65608A (en) | Process for preparation of benzanilide derivatives and pharmaceutical compositions containing them | |
| NZ235726A (en) | Substituted pyrimidine derivatives; their preparation and pharmaceutical compositions | |
| NZ230144A (en) | Phosphorus-substituted purine derivatives and pharmaceutical compositions | |
| PT85551A (en) | Process for the preparation of antiviral pyrimidine derivatives and of pharmaceutical compositions containing the same | |
| HUT60488A (en) | Process for producing pyrimidine derivatives and pharmaceutical compositions comprising same | |
| NZ216951A (en) | Pyrimidine derivatives and pharmaceutical compositions | |
| IL105673A0 (en) | Purine derivatives and pharmaceutical compositions containing them | |
| HUT58303A (en) | Process for producing pyrimidinyl derivatives and pharmaceutical compositions containing them | |
| IL108063A0 (en) | Pharmaceutical compositions containing dideoxy nucleoside analogues | |
| IL105672A0 (en) | Substituted adenosine derivatives and pharmaceutical compositions containing them | |
| HUT70163A (en) | Process for producing pyrrolopyrazine derivatives and pharmaceutical compositions containing them | |
| EP0479640A3 (en) | Novel phosphonate derivatives of certain nucleosides | |
| IL103513A0 (en) | 2,6-disubstituted purine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL91415A0 (en) | Pharmaceutical compositions containing adenosine derivatives | |
| IL108119A0 (en) | Purine derivatives their preparation and pharmaceutical compositions containing them | |
| NZ217342A (en) | 4-amino-n-(alkyl n -p-benzamide derivatives and pharmaceutical compositions | |
| IL101920A0 (en) | Crf analogs and pharmaceutical compositions containing them | |
| IL68972A0 (en) | Pharmaceutical compositions comprising xylosides and lyxosides of purine and pyrimidine bases | |
| IL90639A (en) | Neplanocin derivatives and analogs and pharmaceutical compositions containing them | |
| NZ237484A (en) | Xanthine derivatives and pharmaceutical compositions | |
| PT87550A (pt) | Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same |